Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 985646, 13 pages
http://dx.doi.org/10.1155/2012/985646
Review Article

IgG Placental Transfer in Healthy and Pathological Pregnancies

1Departamento de Pediatria, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 647, Cerqueira César, São Paulo, SP 05403-900, Brazil
2Laboratório de Investigação Médica (LIM-36), Instituto da Criança, Hospital das Clínicas, Av. Dr. Enéas Carvalho de Aguiar, 647, Cerqueira César, São Paulo, SP 05403-900, Brazil
3Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Av. Prof. Lineu Prestes, 1374, Cidade Universitária, São Paulo, SP 05508-000, Brazil

Received 30 June 2011; Accepted 24 July 2011

Academic Editor: Andres Salumets

Copyright © 2012 Patricia Palmeira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Maródi, “Innate cellular immune responses in newborns,” Clinical Immunology, vol. 118, no. 2-3, pp. 137–144, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. O. Levy, “Innate immunity of the newborn: basic mechanisms and clinical correlates,” Nature Reviews Immunology, vol. 7, no. 5, pp. 379–390, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. Y. Weinrauch, C. Abad, N. S. Liang, S. F. Lowry, and J. Weiss, “Mobilization of potent plasma bactericidal activity during systemic bacterial challenge: role of group IIa phospholipase A2,” Journal of Clinical Investigation, vol. 102, no. 3, pp. 633–638, 1998. View at Google Scholar · View at Scopus
  4. M. Koyama, S. Ito, A. Nakajima et al., “Elevations of group II phospholipase A2 concentrations in serum and amniotic fluid in association with preterm labor,” American Journal of Obstetrics and Gynecology, vol. 183, no. 6, pp. 1537–1543, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. T. R. Kollmann, J. Crabtree, A. Rein-Weston et al., “Neonatal innate TLR-mediated responses are distinct from those of adults,” Journal of Immunology, vol. 183, no. 11, pp. 7150–7160, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. PrabhuDas, B. Adkins, H. Gans et al., “Challenges in infant immunity: implications for responses to infection and vaccines,” Nature Immunology, vol. 12, no. 3, pp. 189–194, 2011. View at Publisher · View at Google Scholar · View at PubMed
  7. B. Adkins, C. Leclerc, and S. Marshall-Clarke, “Neonatal adaptive immunity comes of age,” Nature Reviews Immunology, vol. 4, no. 7, pp. 553–564, 2004. View at Google Scholar · View at Scopus
  8. C. J. Haines, T. D. Giffon, L. S. Lu et al., “Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function,” Journal of Experimental Medicine, vol. 206, no. 2, pp. 275–285, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. B. Wilson and T. R. Kollmann, “Induction of antigen-specific immunity in human neonates and infants,” Nestle Nutrition Workshop Series, vol. 61, pp. 183–193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Adkins, C. Leclerc, and S. Marshall-Clarke, “Neonatal adaptive immunity comes of age,” Nature Reviews Immunology, vol. 4, no. 7, pp. 553–564, 2004. View at Google Scholar · View at Scopus
  11. M. A. Firth, P. E. Shewen, and D. C. Hodgins, “Passive and active components of neonatal innate immune defenses,” Animal Health Research Reviews, vol. 6, no. 2, pp. 143–158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. R. B. Webster, Y. Rodriguez, W. T. Klimecki, and D. Vercelli, “The human IL-13 locus in neonatal CD4+ T cells is refractory to the acquisition of a repressive chromatin architecture,” Journal of Biological Chemistry, vol. 282, no. 1, pp. 700–709, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. Rose, M. Lichtenheld, M. R. Foote, and B. Adkins, “Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function,” Journal of Immunology, vol. 178, no. 5, pp. 2667–2678, 2007. View at Google Scholar · View at Scopus
  14. J. E. Mold, J. Michaelsson, T. D. Burt et al., “Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero,” Science, vol. 322, no. 5907, pp. 1562–1565, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. Marshall-Clarke, D. Reen, L. Tasker, and J. Hassan, “Neonatal immunity: how well has it grown up?” Immunology Today, vol. 21, no. 1, pp. 35–41, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. R. L. Schelonka and A. J. Infante, “Neonatal immunology,” Seminars in Perinatology, vol. 22, no. 1, pp. 2–14, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. A. W. Griffioen, S. W. Franklin, B. J. Zegers, and G. T. Rijkers, “Expression and functional characteristics of the complement receptor type 2 on adult and neonatal B lymphocytes,” Clinical Immunology and Immunopathology, vol. 69, no. 1, pp. 1–8, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Klein Klouwenberg and L. Bont, “Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines,” Clinical and Developmental Immunology, vol. 2008, Article ID 628963, 2008. View at Publisher · View at Google Scholar · View at PubMed
  19. N. E. Simister, “Human placental Fc receptors and the trapping of immune complexes,” Vaccine, vol. 16, no. 14-15, pp. 1451–1455, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. F. W. Brambell, W. A. Hemmings, C. L. Oakley, and R. R. Porter, “The relative transmission of the fractions of papain hydrolyzed homologous gamma-globulin from the uterine cavity to the foetal circulation in the rabbit,” Proceedings of the Royal Society of London B, vol. 151, pp. 478–482, 1960. View at Google Scholar · View at Scopus
  21. N. E. Simister and A. R. Rees, “Isolation and characterization of an Fc receptor from neonatal rat small intestine,” European Journal of Immunology, vol. 15, no. 7, pp. 733–738, 1985. View at Google Scholar · View at Scopus
  22. N. E. Simister and K. E. Mostov, “An Fc receptor structurally related to MHC class I antigens,” Nature, vol. 337, no. 6203, pp. 184–187, 1989. View at Google Scholar · View at Scopus
  23. M. Firan, R. Bawdon, C. Radu et al., “The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans,” International Immunology, vol. 13, no. 8, pp. 993–1002, 2001. View at Google Scholar · View at Scopus
  24. E. J. Israel, D. F. Wilsker, K. C. Hayes, D. Schoenfeld, and N. E. Simister, “Increased clearance of IgG in mice that lack β2-microglobulin: possible protective role of FcRn,” Immunology, vol. 89, no. 4, pp. 573–578, 1996. View at Google Scholar · View at Scopus
  25. D. E. Vaughn and P. J. Bjorkman, “Structural basis of pH-dependent antibody binding by the neonatal Fc receptor,” Structure, vol. 6, no. 1, pp. 63–73, 1998. View at Google Scholar · View at Scopus
  26. B. K. Kristoffersen, “Human placental Fc γ-binding proteins in the maternofetal transfer of IgG,” Acta Pathologica, Microbiologica et Immunologica Scandinavica, Supplement, vol. 104, no. 64, pp. 5–36, 1996. View at Google Scholar · View at Scopus
  27. R. J. Ober, C. Martinez, X. Lai, J. Zhou, and E. S. Ward, “Exocytosis of IgG as mediated by the receptor, FcRn: an analysis at the single-molecule level,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 30, pp. 11076–11081, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. N. E. Simister, C. M. Story, H. L. Chen, and J. S. Hunt, “An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta,” European Journal of Immunology, vol. 26, no. 7, pp. 1527–1531, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. L. Radulescu, F. Antohe, V. Jinga, V. Ghetie, and M. Simionescu, “Neonatal Fc receptors discriminates and monitors the pathway of native and modified immunoglobulin G in placental endothelial cells,” Human Immunology, vol. 65, no. 6, pp. 578–585, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. Akilesh, S. Petkova, T. J. Sproule et al., “The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease,” Journal of Clinical Investigation, vol. 113, no. 9, pp. 1328–1333, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Antohe, L. Rǎdulescu, A. Gafencu, V. Gheţie, and M. Simionescu, “Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells,” Human Immunology, vol. 62, no. 2, pp. 93–105, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. N. E. Simister, “Placental transport of immunoglobulin G,” Vaccine, vol. 21, no. 24, pp. 3365–3369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Leach, B. M. Eaton, J. A. Firth, and S. F. Contractor, “Uptake and intracellular routing of peroxidase-conjugated immunoglobulin-G by the perfused human placenta,” Cell and Tissue Research, vol. 261, no. 2, pp. 383–388, 1990. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Fuchs and I. Ellinger, “Endocytic and transcytotic processes in villous syncytiotrophoblast: role in nutrient transport to the human fetus,” Traffic, vol. 5, no. 10, pp. 725–738, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. S. V. Kane and L. A. Acquah, “Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy,” American Journal of Gastroenterology, vol. 104, no. 1, pp. 228–233, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. D. C. Roopenian and S. Akilesh, “FcRn: the neonatal Fc receptor comes of age,” Nature Reviews Immunology, vol. 7, no. 9, pp. 715–725, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. I. Anegon, M. C. Cuturi, G. Trinchieri, and B. Perussia, “Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells,” Journal of Experimental Medicine, vol. 167, no. 2, pp. 452–472, 1988. View at Google Scholar · View at Scopus
  38. M. A. Cassatella, I. Anegon, M. C. Cuturi, P. Griskey, G. Trinchieri, and B. Perussia, “FcγR(CD16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells. Role of Ca2+ in FcγR(CD16)-induced transcription and expression of lymphokine genes,” Journal of Experimental Medicine, vol. 169, no. 2, pp. 549–567, 1989. View at Google Scholar · View at Scopus
  39. F. Saji, Y. Samejima, S. Kamiura, and M. Koyama, “Dynamics of immunoglobulins at the feto-maternal interface,” Reviews of Reproduction, vol. 4, no. 2, pp. 81–89, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Saji, M. Koyama, and N. Matsuzaki, “Current topic: human placental Fc receptors,” Placenta, vol. 15, no. 5, pp. 453–466, 1994. View at Publisher · View at Google Scholar · View at Scopus
  41. H. K. Hartter, O. I. Oyedele, K. Dietz et al., “Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children,” Pediatric Infectious Disease Journal, vol. 19, no. 7, pp. 635–641, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. J. A. Englund, “The influence of maternal immunization on infant immune responses,” Journal of Comparative Pathology, vol. 137, supplement 1, pp. S16–S19, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. B. J. Okoko, L. H. Wesuperuma, M. O. Ota et al., “Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural west African population,” Journal of Health, Population, and Nutrition, vol. 19, no. 2, pp. 59–65, 2001. View at Google Scholar · View at Scopus
  44. J. L. Michaux, J. F. Heremans, and W. H. Hitzig, “Immunoglobulin levels in cord-blood serum of negroes and Caucasians,” Tropical and Geographical Medicine, vol. 18, no. 1, pp. 10–14, 1966. View at Google Scholar · View at Scopus
  45. G. Gonçalves, F. T. Cutts, M. Hills et al., “Transplacental transfer of measles and total IgG,” Epidemiology and Infection, vol. 122, no. 2, pp. 273–279, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. A. L. Silveira Lessa, V. L. Krebs, T. B. Brasil et al., “Preterm and term neonates transplacentally acquire IgG antibodies specific to LPS from Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa,” FEMS Immunology and Medical Microbiology, vol. 62, no. 2, pp. 236–243, 2011. View at Publisher · View at Google Scholar · View at PubMed
  47. R. Mäntyjärvi, T. Hirvonen, and P. Toivanen, “Maternal antibodies in human neonatal sera,” Immunology, vol. 18, no. 3, pp. 449–451, 1970. View at Google Scholar · View at Scopus
  48. M. I. de Moraes-Pinto, A. C. Almeida, G. Kenj et al., “Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection,” Journal of Infectious Diseases, vol. 173, no. 5, pp. 1077–1084, 1996. View at Google Scholar · View at Scopus
  49. H. L. Wesumperuma, A. J. Perera, P. O. Pharoah, and C. A. Hart, “The influence of prematurity and low birthweight on transplacental antibody transfer in Sri Lanka,” Annals of Tropical Medicine and Parasitology, vol. 93, no. 2, pp. 169–177, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Ferrante, L. J. Beard, and R. G. Feldman, “IgG subclass distribution of antibodies to bacterial and viral antigens,” Pediatric Infectious Disease Journal, vol. 9, supplement 8, pp. S16–S24, 1990. View at Google Scholar · View at Scopus
  51. T. Kameda, M. Koyama, N. Matsuzaki, T. Taniguchi, F. Saji, and O. Tanizawa, “Localization of three subtypes of Fcγ receptors in human placenta by immunohistochemical analysis,” Placenta, vol. 12, no. 1, pp. 15–26, 1991. View at Google Scholar · View at Scopus
  52. B. T. Costa-Carvalho, H. M. Vieira, R. B. Dimantas et al., “Transfer of IgG subclasses across placenta in term and preterm newborns,” Brazilian Journal of Medical and Biological Research, vol. 29, no. 2, pp. 201–204, 1996. View at Google Scholar · View at Scopus
  53. A. T. Nagao, B. T. Costa-Carvalho, C. Arslanian et al., “Placental transfer of IgG antibodies against Haemophilus influenzae type b capsular polysaccharide in Brazilian term and preterm newborns,” Journal of Tropical Pediatrics, vol. 45, no. 3, pp. 171–173, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. J. P. van den Berg, E. A. Westerbeek, G. A. Berbers et al., “Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, Haemophilus influenzae type b, and neisseria meningitidis serogroup C is lower in preterm compared with term infants,” Pediatric Infectious Disease Journal, vol. 29, no. 9, pp. 801–805, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. T. Nagao, D. Friedlander-Del Nero, C. Arslanian, and M. M. Carneiro-Sampaio, “Elevated levels and different repertoire profile of colostral anti-LPS antibodies may have a significant role in compensating newborn immunity,” Scandinavian Journal of Immunology, vol. 53, no. 6, pp. 602–609, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. B. J. Okoko, H. L. Wesumperuma, J. Fern, L. K. Yamuah, and C. A. Hart, “The transplacental transfer of IgC subclasses: influence of prematurity and low birthweight in the Gambian population,” Annals of Tropical Paediatrics, vol. 22, no. 4, pp. 325–332, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. A. Malek, R. Sager, P. Kuhn, K. H. Nicolaides, and H. Schneider, “Evolution of maternofetal transport of immunoglobulins during human pregnancy,” American Journal of Reproductive Immunology, vol. 36, no. 5, pp. 248–255, 1996. View at Google Scholar · View at Scopus
  58. P. Palmeira, L. Yu Ito, C. Arslanian, and M. M. Carneiro-Sampaio, “Passive immunity acquisition of maternal anti-enterohemorrhagic Escherichia coli (EHEC) O157:H7 IgG antibodies by the newborn,” European Journal of Pediatrics, vol. 166, no. 5, pp. 413–419, 2007. View at Publisher · View at Google Scholar · View at PubMed
  59. M. Doroudchi, A. Samsami Dehaghani, K. Emad, and A. Ghaderi, “Placental transfer of rubella-specific IgG in fullterm and preterm newborns,” International Journal of Gynecology and Obstetrics, vol. 81, no. 2, pp. 157–162, 2003. View at Publisher · View at Google Scholar
  60. B. T. Costa-Carvalho, H. M. S. Vieira, S. B. Carbonare et al., “Niveles de inmunoglonulinas y lisozimas en sangre de cordon umbilical en recien nacidos de diversas edades gestacionales,” Revista Latinoamericana de Perinatologia, vol. 8, no. 3, pp. 98–105, 1988. View at Google Scholar
  61. J. A. Englund, “Maternal immunization with inactivated influenza vaccine: rationale and experience,” Vaccine, vol. 21, no. 24, pp. 3460–3464, 2003. View at Publisher · View at Google Scholar
  62. F. M. Munoz and J. A. Englund, “A step ahead: infant protection through maternal immunization,” Pediatric Clinics of North America, vol. 47, no. 2, pp. 449–463, 2000. View at Google Scholar
  63. F. M. Munoz and J. A. Englund, “Vaccines in pregnancy,” Infectious Disease Clinics of North America, vol. 15, no. 1, pp. 253–271, 2001. View at Publisher · View at Google Scholar
  64. J. A. Englund, I. N. Mbawuike, H. Hammill et al., “Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants,” Journal of Infectious Diseases, vol. 168, no. 3, pp. 647–656, 1993. View at Google Scholar
  65. D. P. Yeager, E. C. Toy, and B. Baker, “Influenza vaccination in pregnancy,” American Journal of Perinatology, vol. 16, no. 6, pp. 283–286, 1999. View at Google Scholar
  66. I. Benowitz, D. B. Esposito, K. D. Gracey, E. D. Shapiro, and M. Vazquez, “Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants,” Clinical Infectious Diseases, vol. 51, no. 12, pp. 1355–1361, 2010. View at Publisher · View at Google Scholar · View at PubMed
  67. K. A. Poehling, P. G. Szilagyi, M. A. Staat et al., “Impact of maternal immunization on influenza hospitalizations in infants,” American Journal of Obstetrics and Gynecology, vol. 204, supplement 6, pp. S141–S148, 2011. View at Publisher · View at Google Scholar · View at PubMed
  68. A. A. Eick, T. M. Uyeki, A. Klimov et al., “Maternal influenza vaccination and effect on influenza virus infection in young infants,” Archives of Pediatrics and Adolescent Medicine, vol. 165, no. 2, pp. 104–111, 2011. View at Publisher · View at Google Scholar · View at PubMed
  69. K. Zaman, E. Roy, S. E. Arifeen et al., “Effectiveness of maternal influenza immunization in mothers and infants,” New England Journal of Medicine, vol. 359, no. 15, pp. 1555–1564, 2008. View at Publisher · View at Google Scholar · View at PubMed
  70. S. A. Gall, J. Myers, and M. Pichichero, “Maternal immunization with tetanusdiphtheriapertussis vaccine: effect on maternal and neonatal serum antibody levels,” American Journal of Obstetrics and Gynecology, vol. 204, no. 4, pp. 334.e1–334.e5, 2011. View at Publisher · View at Google Scholar · View at PubMed
  71. M. H. Nahm, P. Glezen, and J. Englund, “The influence of maternal immunization on light chain response to Haemophilus influenzae type b vaccine,” Vaccine, vol. 21, no. 24, pp. 3393–3397, 2003. View at Publisher · View at Google Scholar
  72. W. P. Glezen, J. A. Englund, G. R. Siber et al., “Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b,” Journal of Infectious Diseases, vol. 165, supplement 1, pp. S134–S136, 1992. View at Google Scholar
  73. J. A. Englund, W. P. Glezen, C. Turner et al., “Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines,” Journal of Infectious Diseases, vol. 171, no. 1, pp. 99–105, 1995. View at Google Scholar
  74. J. A. Englund, W. P. Glezen, C. Thompson et al., “Haemophilus influenzae type b-specific antibody in infants after maternal immunization,” Pediatric Infectious Disease Journal, vol. 16, no. 12, pp. 1122–1130, 1997. View at Publisher · View at Google Scholar
  75. K. Mulholland, R. O. Suara, G. Siber et al., “Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia,” Journal of the American Medical Association, vol. 275, no. 15, pp. 1182–1188, 1996. View at Google Scholar
  76. C. J. Baker, M. A. Rench, and P. McInnes, “Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine,” Vaccine, vol. 21, no. 24, pp. 3468–3472, 2003. View at Publisher · View at Google Scholar
  77. L. Baril, D. E. Briles, P. Crozier et al., “Natural materno-fetal transfer of antibodies to PspA and to PsaA,” Clinical and Experimental Immunology, vol. 135, no. 3, pp. 474–477, 2004. View at Publisher · View at Google Scholar
  78. D. Lehmann, W. S. Pomat, I. D. Riley, and M. P. Alpers, “Studies of maternal immunisation with pneumococcal polysaccharide vaccine in Papua New Guinea,” Vaccine, vol. 21, no. 24, pp. 3446–3450, 2003. View at Publisher · View at Google Scholar
  79. B. P. Quiambao, H. M. Nohynek, H. Käyhty et al., “Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies,” Vaccine, vol. 25, no. 22, pp. 4470–4477, 2007. View at Publisher · View at Google Scholar · View at PubMed
  80. B. P. Quiambao, H. Nohynek, H. Käyhty et al., “Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines,” Vaccine, vol. 21, no. 24, pp. 3451–3454, 2003. View at Publisher · View at Google Scholar
  81. V. D. C. Almeida, M. M. Mussi-Pinhata, C. B. De Souza et al., “Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants,” Vaccine, vol. 27, no. 29, pp. 3856–3861, 2009. View at Publisher · View at Google Scholar · View at PubMed
  82. F. M. Munoz, J. A. Englund, C. C. Cheesman et al., “Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation,” Vaccine, vol. 20, no. 5-6, pp. 826–837, 2001. View at Publisher · View at Google Scholar
  83. G. Vidarsson, S. T. Sigurdardottir, T. Gudnason et al., “Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B- tetanus toxoid vaccine,” Infection and Immunity, vol. 66, no. 6, pp. 2866–2870, 1998. View at Google Scholar
  84. C. A. Siegrist, “Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants,” Vaccine, vol. 21, no. 24, pp. 3406–3412, 2003. View at Publisher · View at Google Scholar
  85. H. Gans, R. DeHovitz, B. Forghani et al., “Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life,” Vaccine, vol. 21, no. 24, pp. 3398–3405, 2003. View at Publisher · View at Google Scholar
  86. H. Gans, L. Yasukawa, M. Rinki et al., “Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months,” Journal of Infectious Diseases, vol. 184, no. 7, pp. 817–826, 2001. View at Publisher · View at Google Scholar · View at PubMed
  87. H. A. Gans, A. M. Arvin, J. Galinus et al., “Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months,” Journal of the American Medical Association, vol. 280, no. 6, pp. 527–532, 1998. View at Publisher · View at Google Scholar
  88. W. P. Glezen, “Effect of maternal antibodies on the infant immune response,” Vaccine, vol. 21, no. 24, pp. 3389–3392, 2003. View at Publisher · View at Google Scholar
  89. C. A. Siegrist and R. Aspinall, “B-cell responses to vaccination at the extremes of age,” Nature Reviews Immunology, vol. 9, no. 3, pp. 185–194, 2009. View at Publisher · View at Google Scholar · View at PubMed
  90. J. Bonhoeffer, C. A. Siegrist, and P. T. Heath, “Immunisation of premature infants,” Archives of Disease in Childhood, vol. 91, no. 11, pp. 929–935, 2006. View at Publisher · View at Google Scholar · View at PubMed
  91. J. N. Bulmer, F. N. Rasheed, L. Morrison, N. Francis, and B. M. Greenwood, “Placental malaria. II. A semi-quantitative investigation of the pathological features,” Histopathology, vol. 22, no. 3, pp. 219–225, 1993. View at Google Scholar
  92. M. I. de Moraes-Pinto, F. Verhoeff, L. Chimsuku et al., “Placental antibody transfer: influence of maternal HIV infection and placental malaria,” Archives of Disease in Childhood, vol. 79, no. 3, pp. F202–F205, 1998. View at Google Scholar
  93. M. Fried, R. O. Muga, A. O. Misore, and P. E. Duffy, “Malaria elicits type 1 cytokines in the human placenta: IFN-γ and TNF-α associated with pregnancy outcomes,” Journal of Immunology, vol. 160, no. 5, pp. 2523–2530, 1998. View at Google Scholar
  94. L. A. Beebe, L. D. Cowan, and G. Altshuler, “The epidemiology of placental features: associations with gestational age and neonatal outcome,” Obstetrics and Gynecology, vol. 87, no. 5, part 1, pp. 771–778, 1996. View at Publisher · View at Google Scholar
  95. M. E. Brair, B. J. Brabin, P. Milligan, S. Maxwell, and C. A. Hart, “Reduced transfer of tetanus antibodies with placental malaria,” The Lancet, vol. 343, no. 8891, pp. 208–209, 1994. View at Publisher · View at Google Scholar
  96. M. I. de Moraes-Pinto, C. K. Farhat, S. B. Carbonare et al., “Maternally acquired immunity in newborns from women infected by the human immunodeficiency virus,” Acta Paediatrica, International Journal of Paediatrics, vol. 82, no. 12, pp. 1034–1038, 1993. View at Google Scholar
  97. C. Farquhar, R. Nduati, N. Haigwood et al., “High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody,” Journal of Acquired Immune Deficiency Syndromes, vol. 40, no. 4, pp. 494–497, 2005. View at Publisher · View at Google Scholar
  98. P. Cumberland, C. E. Shulman, P. A. Maple et al., “Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya,” Journal of Infectious Diseases, vol. 196, no. 4, pp. 550–557, 2007. View at Publisher · View at Google Scholar · View at PubMed
  99. S. Scott, P. Cumberland, C. E. Shulman et al., “Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples,” Journal of Infectious Diseases, vol. 191, no. 11, pp. 1854–1860, 2005. View at Publisher · View at Google Scholar · View at PubMed
  100. C. E. Jones, S. Naidoo, C. De Beer et al., “Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants,” Journal of the American Medical Association, vol. 305, no. 6, pp. 576–584, 2011. View at Publisher · View at Google Scholar · View at PubMed
  101. M. Berger, T. R. Cupps, and A. S. Fauci, “High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy,” Journal of the American Medical Association, vol. 247, no. 20, pp. 2824–2825, 1982. View at Publisher · View at Google Scholar
  102. C. Cunningham-Rundles and C. Bodian, “Common variable immunodeficiency: clinical and immunological features of 248 patients,” Clinical Immunology, vol. 92, no. 1, pp. 34–48, 1999. View at Publisher · View at Google Scholar · View at PubMed
  103. H. Eibel, U. Salzer, and K. Warnatz, “Common variable immunodeficiency at the end of a prospering decade: towards novel gene defects and beyond,” Current Opinion in Allergy and Clinical Immunology, vol. 10, no. 6, pp. 526–533, 2010. View at Publisher · View at Google Scholar · View at PubMed
  104. N. Vitoratos, P. Bakas, H. Kalampani, and G. Creatsas, “Maternal common variable immunodeficiency and pregnancy,” Journal of Obstetrics and Gynaecology, vol. 19, no. 6, pp. 654–655, 1999. View at Google Scholar
  105. A. Gardulf, E. Anderson, M. Lindqvist, S. Hansen, and R. Gustafson, “Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women,” Journal of Clinical Immunology, vol. 21, no. 2, pp. 150–154, 2001. View at Publisher · View at Google Scholar
  106. O. A. Olatunbosun, “Hypogammaglobulinemia associated with pregnancy,” International Journal of Gynecology and Obstetrics, vol. 40, no. 2, pp. 162–163, 1993. View at Publisher · View at Google Scholar
  107. P. Palmeira, B. T. Costa-Carvalho, C. Arslanian et al., “Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin,” Pediatric Allergy and Immunology, vol. 20, no. 6, pp. 528–535, 2009. View at Publisher · View at Google Scholar · View at PubMed
  108. R. Kobayashi, S. Mii, T. Nakano, H. Harada, and H. Eto, “Neonatal lupus erythematosus in Japan: a review of the literature,” Autoimmunity Reviews, vol. 8, no. 6, pp. 462–466, 2009. View at Publisher · View at Google Scholar · View at PubMed
  109. D. M. Friedman, M. Y. Kim, J. A. Copel et al., “Utility of cardiac monitoring in fetuses at risk for congenital heart block : the PR interval and dexamethasone evaluation (PRIDE) prospective study,” Circulation, vol. 117, no. 4, pp. 485–493, 2008. View at Publisher · View at Google Scholar · View at PubMed
  110. M. C. Escobar, J. A. Gómez-Puerta, D. Albert, Q. Ferrer, and J. Girona, “Recurrent congenital heart block in neonatal lupus,” Clinical Rheumatology, vol. 26, no. 7, pp. 1161–1163, 2007. View at Publisher · View at Google Scholar · View at PubMed
  111. E. A. Stea, J. G. Routsias, R. M. Clancy et al., “Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring,” Arthritis and Rheumatism, vol. 54, no. 7, pp. 2228–2234, 2006. View at Publisher · View at Google Scholar · View at PubMed
  112. T. Parlowsky, J. Welzel, M. Amagai, D. Zillikens, and T. Wygold, “Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns,” Journal of the American Academy of Dermatology, vol. 48, no. 4, pp. 623–625, 2003. View at Publisher · View at Google Scholar · View at PubMed
  113. A. Campo-Voegeli, F. Muñiz, J. M. Mascaró et al., “Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris,” British Journal of Dermatology, vol. 147, no. 4, pp. 801–805, 2002. View at Publisher · View at Google Scholar
  114. M. Saint-Faust, S. Perelman, D. Dupont, P. Velin, and M. Chatel, “Transient neonatal myasthenia gravis revealing a myasthenia gravis and a systemic lupus erythematosus in the mother: case report and review of the literature,” American Journal of Perinatology, vol. 27, no. 2, pp. 107–110, 2010. View at Publisher · View at Google Scholar · View at PubMed
  115. A. Tincani, C. B. Rebaioli, L. Andreoli, A. Lojacono, and M. Motta, “Neonatal effects of maternal antiphospholipid syndrome,” Current Rheumatology Reports, vol. 11, no. 1, pp. 70–76, 2009. View at Publisher · View at Google Scholar
  116. M. L. Abrams, A. Smidt, L. Benjamin et al., “Congenital epidermolysis bullosa acquisita: vertical transfer of maternal autoantibody from mother to infant,” Archives of Dermatology, vol. 147, no. 3, pp. 337–341, 2011. View at Publisher · View at Google Scholar · View at PubMed
  117. Z. Yu and V. A. Lennon, “Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases,” New England Journal of Medicine, vol. 340, no. 3, pp. 227–228, 1999. View at Publisher · View at Google Scholar · View at PubMed
  118. A. Samuelsson, T. L. Towers, and J. V. Ravetch, “Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor,” Science, vol. 291, no. 5503, pp. 484–486, 2001. View at Publisher · View at Google Scholar · View at PubMed
  119. N. Li, M. Zhao, J. Hilario-Vargas et al., “Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases,” Journal of Clinical Investigation, vol. 115, no. 12, pp. 3440–3450, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  120. R. J. Hansen and J. P. Balthasar, “Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor,” Thrombosis and Haemostasis, vol. 88, no. 6, pp. 898–899, 2002. View at Google Scholar
  121. N. Li, M. Zhao, J. Hilario-Vargas et al., “Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases,” Journal of Clinical Investigation, vol. 115, no. 12, pp. 3440–3450, 2005. View at Publisher · View at Google Scholar · View at PubMed
  122. R. Kaaja and H. Julkunen, “Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al,” Arthritis and Rheumatism, vol. 48, no. 1, pp. 280–282, 2003. View at Publisher · View at Google Scholar · View at PubMed
  123. H. B. Tran, D. Cavill, J. P. Buyon, and T. P. Gordon, “Intravenous immunoglobulin and placental transport of anti-Ro/La antibodies: comment on the letter by Kaaja and Julkunen,” Arthritis and Rheumatism, vol. 50, no. 1, pp. 337–338, 2004. View at Publisher · View at Google Scholar · View at PubMed
  124. D. W. Branch, A. M. Peaceman, M. Druzin et al., “A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy,” American Journal of Obstetrics and Gynecology, vol. 182, no. 1, part 1, pp. 122–127, 2000. View at Google Scholar
  125. R. L. Berkowitz, M. L. Lesser, J. G. McFarland et al., “Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial,” Obstetrics and Gynecology, vol. 110, no. 2, part 1, pp. 249–255, 2007. View at Publisher · View at Google Scholar · View at PubMed
  126. H. Lemke, A. Coutinho, and H. Lange, “Lamarckian inheritance by somatically acquired maternal IgG phenotypes,” Trends in Immunology, vol. 25, no. 4, pp. 180–186, 2004. View at Publisher · View at Google Scholar · View at PubMed
  127. R. Casas and B. Björkstén, “Detection of Fel d 1-immunoglobulin G immune complexes in cord blood and sera from allergic and non-allergic mothers,” Pediatric Allergy and Immunology, vol. 12, no. 2, pp. 59–64, 2001. View at Publisher · View at Google Scholar